Swiss drug major Novartis AG (NVS) reported Tuesday higher profit and net sales in its first quarter. Further, the company raised its fiscal 2025 outlook.
For the year, the company now projects core operating income to grow low double-digit and sales to grow high single digit from the prior year.
The company previously expected core operating income to grow high single to low double-digit and net sales to grow mid- to high-single digit.
In its first quarter, net income climbed 34 percent to $3.61 billion from last year's $2.69 billion. Earnings per share were $1.83, up 40 percent from $1.31 last year.
Core net income was $4.48 billion, compared to $3.68 billion a year ago. Core earnings per share were $2.28, compared to $1.80 last year.
Net sales to third parties increased 12 percent to $13.23 billion from last year's $11.83 billion, with volume contributing 15 percentage points to growth. At constant currencies, net sales grew 15%.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.